Yüklüyor......

Human mast cells decrease SLPI levels in type II – like alveolar cell model, in vitro

BACKGROUND: Mast cells are known to accumulate at sites of inflammation and upon activation to release their granule content, e.g. histamine, cytokines and proteases. The secretory leukocyte protease inhibitor (SLPI) is produced in the respiratory mucous and plays a role in regulating the activity o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Hollander, Camilla, Nyström, Max, Janciauskiene, Sabina, Westin, Ulla
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2003
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC194615/
https://ncbi.nlm.nih.gov/pubmed/12952550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-3-14
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!